Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Webb

Showing results (311-320 of 323) with videos related to

Pageof 33
Sort By:
Lancet (London, England)|December 3, 2013
Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trialD Nicholas Bateman, James W Dear, H K Ruben Thanacoody, et al.
Eclinicalmedicine|July 19, 2019
Safety and Efficacy of the SNAP 12-hour Acetylcysteine Regimen for the Treatment of Paracetamol OverdoseJanice M Pettie, Thomas M Caparrotta, Robert W Hunter, et al.
Journal of Hypertension|January 22, 2005
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of HypertensionHanspeter Brunner, John R Cockcroft, John Deanfield, et al.
Hypertension (Dallas, Tex. : 1979)|December 29, 2016
Smooth Muscle Endothelin B Receptors Regulate Blood Pressure but Not Vascular Function or Neointimal RemodelingEileen Miller, Alicja Czopek, Karolina M Duthie, et al.
Lancet (London, England)|October 14, 2022
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trialIsla S Mackenzie, Amy Rogers, Neil R Poulter, et al.
Hypertension (Dallas, Tex. : 1979)|March 24, 2020
Endothelin-1 Mediates the Systemic and Renal Hemodynamic Effects of GPR81 ActivationNatalie K Jones, Kevin Stewart, Alicja Czopek, et al.
Drugs in R&D|August 24, 2017
Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled TrialDavid J Webb, Blai Coll, Hiddo J L Heerspink, et al.
Clinical Pharmacology and Therapeutics|January 31, 2022
Acetylcysteine has No Mechanistic Effect in Patients at Risk of Contrast-Induced Nephropathy: A Failure of Academic Clinical ScienceEuan A Sandilands, Jessica M B Rees, Khuram Raja, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 31, 2021
Effects of Spironolactone and Chlorthalidone on Cardiovascular Structure and Function in Chronic Kidney Disease: A Randomized, Open-Label TrialNicola C Edwards, Anna M Price, Samir Mehta, et al.
JCI Insight|December 13, 2016
Chorioretinal thinning in chronic kidney disease links to inflammation and endothelial dysfunctionCraig Balmforth, Job Jmh van Bragt, Titia Ruijs, et al.
Pageof 33

Showing results (311-320 of 323) with videos related to

Sort By:
Pageof 33
Lancet (London, England)|December 3, 2013
Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trialD Nicholas Bateman, James W Dear, H K Ruben Thanacoody, et al.
Eclinicalmedicine|July 19, 2019
Safety and Efficacy of the SNAP 12-hour Acetylcysteine Regimen for the Treatment of Paracetamol OverdoseJanice M Pettie, Thomas M Caparrotta, Robert W Hunter, et al.
Journal of Hypertension|January 22, 2005
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of HypertensionHanspeter Brunner, John R Cockcroft, John Deanfield, et al.
Hypertension (Dallas, Tex. : 1979)|December 29, 2016
Smooth Muscle Endothelin B Receptors Regulate Blood Pressure but Not Vascular Function or Neointimal RemodelingEileen Miller, Alicja Czopek, Karolina M Duthie, et al.
Lancet (London, England)|October 14, 2022
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trialIsla S Mackenzie, Amy Rogers, Neil R Poulter, et al.
Hypertension (Dallas, Tex. : 1979)|March 24, 2020
Endothelin-1 Mediates the Systemic and Renal Hemodynamic Effects of GPR81 ActivationNatalie K Jones, Kevin Stewart, Alicja Czopek, et al.
Drugs in R&D|August 24, 2017
Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled TrialDavid J Webb, Blai Coll, Hiddo J L Heerspink, et al.
Clinical Pharmacology and Therapeutics|January 31, 2022
Acetylcysteine has No Mechanistic Effect in Patients at Risk of Contrast-Induced Nephropathy: A Failure of Academic Clinical ScienceEuan A Sandilands, Jessica M B Rees, Khuram Raja, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 31, 2021
Effects of Spironolactone and Chlorthalidone on Cardiovascular Structure and Function in Chronic Kidney Disease: A Randomized, Open-Label TrialNicola C Edwards, Anna M Price, Samir Mehta, et al.
JCI Insight|December 13, 2016
Chorioretinal thinning in chronic kidney disease links to inflammation and endothelial dysfunctionCraig Balmforth, Job Jmh van Bragt, Titia Ruijs, et al.
Pageof 33